Pharmaceutical Research Overview
Ultima-NPP 150 is a pharmaceutical-grade nandrolone phenylpropionate research solution manufactured by Ultima Pharmaceuticals for advanced laboratory investigations. This anabolic steroid research compound features precise 150mg/ml concentration in sterile injection format, enabling researchers to examine nandrolone phenylpropionate’s molecular interactions with androgen receptor systems. Unlike longer-acting nandrolone esters, this phenylpropionate variant provides researchers with shorter detection windows for controlled laboratory studies. Researchers investigating anabolic steroid mechanisms rely on compounds like Ultima-NPP 150 to understand tissue-selective androgenic activity in cell culture models.
Laboratory Research Applications
Research scientists utilise Ultima-NPP 150 to investigate nandrolone’s binding affinity at androgen receptors compared to other anabolic compounds available through Stroid UK Shop. This pharmaceutical research tool enables examination of anabolic-to-androgenic ratios in controlled laboratory environments. Comparative studies often evaluate nandrolone phenylpropionate alongside other research compounds from the steroid injections collection to understand molecular structure-activity relationships. Research institutions studying hormone replacement mechanisms examine how shorter-ester nandrolone compounds interact with cellular androgen receptor systems. Scientists also investigate metabolic pathways and enzymatic conversion processes in hepatic cell culture studies. Advanced research protocols compare nandrolone phenylpropionate with other research chemicals including those from SARMs categories and peptide research compounds to evaluate tissue selectivity profiles.
Research Compound Specifications
| Active Compound | Nandrolone Phenylpropionate |
|---|---|
| Concentration | 150mg/ml |
| Manufacturer | Ultima Pharmaceuticals |
| Format | Injectable Research Solution |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Conditions | Room temperature, sterile environment |
| Intended Use | In-vitro research only |
Research Compliance Statement
Ultima-NPP 150 is manufactured exclusively for qualified research institutions conducting in-vitro laboratory studies on anabolic steroid receptor mechanisms. This pharmaceutical research compound is not intended for human consumption, therapeutic application, or veterinary use. Research facilities must maintain proper laboratory protocols and documentation when handling this controlled research substance. All investigations must comply with institutional research guidelines and applicable laboratory safety regulations for anabolic steroid research compounds.
